Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia Cells
12%
Age-matched
12%
Ann Arbor Staging
19%
Anticoagulants
25%
B Cells
12%
Bacillary Dysentery
12%
Biomarker Analysis
12%
Blast Cells
12%
Bone Marrow Aspiration
17%
Breast Cancer
32%
Breast Cancer Patients
40%
Breast Cancer Stage
12%
Breast Cancer Stem Cells
12%
C-Myc
12%
C-reactive Protein
20%
Cancer Stem Cells
12%
Carbohydrate Antigen 15-3
12%
Cell Line Development
12%
Cell Population
18%
Chelation
12%
Chemotherapy
32%
Chemotherapy-induced Neutropenia
12%
Chronic Kidney Disease
29%
Chronic Lymphocytic Leukemia
12%
Chronic Myeloid Leukemia
51%
Clinical Integration
14%
Complementary Modalities
12%
Continuous Cell Lines
12%
Convalescent Plasma
16%
Convalescent Plasma Therapy
25%
COVID-19
46%
COVID-19 Patients
18%
Critically Ill COVID-19 Patients
25%
Cross-cultural Analysis
12%
Cyclophosphamide
24%
D-dimer
13%
Decompensated Cirrhosis
25%
Dedifferentiation
12%
Diagnostic Challenge
12%
Diagnostic Value
17%
Difference Expression
12%
Diffuse Large B-cell Lymphoma (DLBCL)
40%
Disease Progression
14%
Disease Score
25%
Disseminated Histoplasmosis
12%
Doxorubicin
23%
Duration of Therapy
12%
Early Detection
18%
Early Molecular Response
12%
Enriched Culture
12%
Fibrinogen
23%
Filgrastim
12%
Financial Outcomes
12%
Hasford Score
12%
Hematologic
14%
Hematological Malignancies
24%
Hematology Analyzer
25%
High-sensitivity Troponin T
12%
Imatinib
15%
Imatinib Therapy
17%
Indonesia
30%
Iron Overload
31%
John Cunningham Virus
12%
Leukemia Patients
30%
Limited Resources
14%
Lymphoma Patients
30%
Malignancy
21%
MCF-7
12%
MELD Score
25%
MicroRNA-21 (miR-21)
38%
Moderate to Severe
25%
Neutrophil-lymphocyte Ratio
20%
Non-Hodgkin Lymphoma
54%
Out-of-pocket Payments
12%
Plasma Fibrinogen
25%
Plasma microRNA
12%
Plasma miRNAs
25%
Precursor Cells
12%
Priapism
12%
Progressive multifocal Leukoencephalopathy
12%
R-CHOP Chemotherapy
15%
Rare Manifestation
25%
Referral Hospital
25%
Renal Complications
12%
Reticulocyte Hemoglobin Equivalent (RET-He)
12%
Scattergram
25%
Screening Biomarker
12%
Sepsis
14%
Serum Ferritin
36%
Severe COVID-19 Patients
25%
Smoldering multiple Myeloma
12%
Surabaya
49%
Survival Prediction
12%
TAC Chemotherapy
12%
Thalassemia
29%
Therapy Response
12%
Transfusion Requirements
12%
Transfusion-dependent Thalassemia
14%
Waldenström Macroglobulinemia
12%
β-Thalassemia (β-thal)
25%
Medicine and Dentistry
Acute Myeloid Leukemia
12%
Acute Pancreatitis
12%
Anemia
19%
Anticoagulant
18%
Antithrombotic
16%
B Cell
12%
B-Cell Chronic Lymphocytic Leukemia
12%
Beta Thalassemia
17%
Biological Marker
17%
Blast Cell
12%
Bone Marrow Biopsy
17%
Breast Cancer
25%
Breast Cancer Chemotherapy
12%
C Reactive Protein
33%
C-Terminal Telopeptide
12%
Cancer
27%
Cancer Stem Cell
12%
Capecitabine
12%
Cardiotoxicity
23%
Cardiovascular Risk
12%
Cardiovascular System
12%
Case Presentation
12%
Cell Culture
12%
Cell Dedifferentiation
12%
Cell Line
12%
Cell Population
12%
Cerebral Hemorrhage
12%
Chemotherapy
24%
Chloroquine
12%
CHOP
21%
Chronic Kidney Disease
25%
Chronic Leukemia
12%
Chronic Myelogenous Leukemia
51%
Complementary Medicine
12%
Coronavirinae
12%
COVID-19
77%
Cross Sectional Study
22%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
15%
Cytarabine
12%
Diagnosis
25%
Diffuse Large B-Cell Lymphoma
32%
Disease Exacerbation
16%
Diseases
57%
Doxorubicin
36%
Dysentery
12%
Evans Syndrome
12%
Ferritin
13%
First Trimester Pregnancy
12%
Gene Mutation
14%
Health Care Cost
19%
Heart Left Ventricle Ejection Fraction
18%
Hematology
12%
Histoplasmosis
12%
Hospital Inpatient
12%
Hydroxychloroquine
12%
Hypochromic Anemia
17%
Imatinib
12%
Ineffective Erythropoiesis
12%
Infection
13%
Iron Chelating Agent
12%
Iron Overload
34%
JC Virus
12%
Large Cell
12%
Leukemia Cell
12%
Liposomal Daunorubicin
12%
Lung Cancer
12%
Lymphocyte
42%
Lymphoma Cell
12%
Malignant Neoplasm
16%
MCF-7
12%
Medical Oncology
12%
Neoplasm
17%
Neutrophil
34%
Next Generation Sequencing
25%
Non-Hodgkin Lymphoma
61%
Pancytopenia
12%
Pericardial Fluid
12%
Placebo
12%
Precursor
12%
Predictive Factor
12%
Prednisolone
12%
Prednisone
31%
Prevalence
22%
Priapism
12%
Primary Health Care
12%
Progressive Multifocal Leukoencephalopathy
12%
Prospective Cohort Study
15%
Reticulocyte
12%
Sepsis
16%
Side Effect
12%
Smouldering Myeloma
12%
Splenomegaly
21%
Systematic Review
12%
Systolic Function
12%
Tamponade
12%
Thalassemia Major
25%
Treatment Response
17%
Troponin T
12%
Vincristine
24%
Waldenström's Macroglobulinemia
12%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
11%
Acute Myeloid Leukemia
12%
Acute Pancreatitis
12%
Adenocarcinoma
12%
Albright Syndrome
11%
Anemia
14%
Anticoagulant Agent
27%
Beta Thalassemia
17%
Biological Marker
30%
Blood Clotting Disorder
16%
Breast Cancer
25%
C Reactive Protein
33%
Capecitabine
12%
Carcinogenesis
12%
Cardiotoxicity
23%
Cell Culture
12%
Chelating Agent
12%
Chelation Therapy
10%
Chemotherapy
100%
Chloroquine
12%
Cholesterol
12%
Chronic Kidney Failure
30%
Chronic Lymphatic Leukemia
12%
Chronic Myeloid Leukemia
51%
Collagen Type 1
12%
Colorectal Carcinoma
12%
Coronavirinae
38%
Coughing
6%
Cross-Sectional Study
23%
Cyclophosphamide
21%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
15%
Cytarabine
12%
D Dimer
14%
Daunorubicin
12%
Decompensated Liver Cirrhosis
25%
Deep Vein Thrombosis
12%
Delta Variant
6%
Diffuse Large B Cell Lymphoma
34%
Disease Exacerbation
12%
Diseases
79%
Docetaxel
12%
Doxorubicin
33%
Dyspnea
10%
End Stage Liver Disease
25%
Erythroferrone
5%
Ethylenediaminetetraacetic Acid
6%
Febrile Neutropenia
5%
Ferritin
26%
Fibrinogen
28%
Filgrastim
12%
Gemcitabine
12%
Haemophilia A
12%
Helicobacter Infection
12%
Helicobacter Pylori
12%
Hematologic Malignancy
15%
Histone
6%
Hydroxychloroquine
12%
Imatinib
38%
Infection
23%
Inflammation
12%
Interleukin 10
12%
Iron
10%
Iron Deficiency Anemia
17%
Iron Poisoning
38%
Ischemic Heart Disease
12%
JC Virus
12%
Lactate Dehydrogenase
10%
Malignant Neoplasm
13%
microRNA 21
12%
Mortality Rate
5%
Neoplasm
22%
Neutropenia
12%
Nonhodgkin Lymphoma
62%
Observational Study
8%
Osteocalcin
12%
Oxidized Low Density Lipoprotein
12%
Pathogenesis
12%
Peripheral Occlusive Artery Disease
12%
Placebo
12%
Prednisolone
12%
Prednisone
21%
Progressive Multifocal Leukoencephalopathy
12%
Protein Tyrosine Kinase Inhibitor
14%
Rituximab
5%
Sepsis
17%
Short Stature
10%
Side Effect
6%
Splenomegaly
8%
Survival Prediction
12%
Telopeptide
12%
Thalassemia
25%
Thalassemia Major
25%
Thrombocytopenia
12%
Thrombosis
15%
Troponin T
12%
Vincristine
21%
Weakness
6%